S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

IKT Inhibikase Therapeutics Inc

2.63

-0.34 (-11.45%)

Last Updated: 06:27:04

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Inhibikase Therapeutics Charts.

Inhibikase Therapeutics (NASDAQ:IKT)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Inhibikase Therapeutics Charts.

Inhibikase Therapeutics Inc News

Form 8-K - Current report
Tuesday 25 February 2025 (6 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 19 February 2025 (6 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 15 February 2025 (1 week ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (1 week ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

More Inhibikase Therapeutics Inc News Articles

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions